Analytical Data
-
基因名
VP30
- Application
-
别名
VP30；TRBP；RISC-loading complex subunit TARBP2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q77DJ5
-
表达区间
1-288aa
-
氨基酸序列
MEASYERGRPRAARQHSRDGHDHHVRARSSSRENYRGEYRQSRSASQVRVPTVFHKKRVEPLTVPPAPKDICPTLKKGFLCDSSFCKKDHQLESLTDRELLLLIARKTCGSVEQQLNITAPKDSRLANPTADDFQQEEGPKITLLTLIKTAEHWARQDIRTIEDSKLRALLTLCAVMTRKFSKSQLSLLCETHLRREGLGQDQAEPVLEVYQRLHSDKGGSFEAALWQQWDRQSLIMFITAFLNIALQLPCESSAVVVSGLRTLVPQSDNEEASTNPGTCSWSDEGTP
-
分子量
38.0kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VP30 is a crucial protein associated with the Ebola virus, belonging to the family of filoviruses, which are known for their high pathogenicity and fatality rates in humans. The research surrounding VP30 is primarily driven by its role as a transcription factor that is essential for viral RNA synthesis and replication. Understanding the molecular mechanisms of VP30 is vital for developing effective antiviral strategies, as it facilitates viral gene expression and plays a key role in viral assembly. Moreover, VP30 is involved in interacting with other viral proteins and cellular factors, suggesting it may be a potential target for therapeutic interventions. Given the lack of effective treatments for Ebola, studying VP30 not only enhances our understanding of filovirus biology but also aids in the design of novel vaccines and antiviral drugs. The urgent need to address outbreaks of Ebola virus disease further underscores the significance of VP30 research in the context of global health and biodefense. As such, elucidating the structural and functional properties of VP30 is a priority in the field of virology, contributing to the broader effort to mitigate the impact of Ebola and similar viral pathogens.
